US 11590184
Oncolytic rhabdovirus expressing IL12
granted A61KA61K35/766A61K35/768
Quick answer
US patent 11590184 (Oncolytic rhabdovirus expressing IL12) held by TURNSTONE LIMITED PARTNERSHIP expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TURNSTONE LIMITED PARTNERSHIP
- Grant date
- Tue Feb 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61K, A61K35/766, A61K35/768, A61K38/20, A61K38/208